U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Blood, Vaccines and Other Biologics
  5. Blood Products Advisory Committee
  6. Roster of the Blood Products Advisory Committee
  1. Blood Products Advisory Committee

Roster of the Blood Products Advisory Committee

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 1

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson****
Zbigniew Szczepiorkowski, M.D., PhD, F.C.A.P.
Expertise: Transfusion Medicine/Laboratory Medicine
Term: 10/18/2022-9/30/2026
Professor of Pathology and Laboratory
Medicine
Professor of Medicine
Dartmouth’s Geisel School of Medicine
Medical Director, Transfusion Medicine 
Service
Director, Cell Labeling Laboratory
Dartmouth-Hitchcock Medical Center
Lebanon, NH 03756
Sanjay P. Ahuja, M.D., M.Sc., M.B.A.
Expertise: Pediatric/Hematology/Coagulation
Term: 10/01/2023-9/30/2027
Professor, Case Western Reserve University 
Dominic Piunno Endowed Chair in Hemophilia & Bleeding Disorders
Distinguished Physician, University Hospitals
Clinical Director, Pediatric Hematology/Oncology
Director, Rainbow Hemostasis & Thrombosis Center
Rainbow Babies & Children’s Hospital
Cleveland, OH 44106

Mark Ballow, M.D.
Expertise: Allergy & Immunology 
Term: 01/27/2020-9/30/2027
Professor
Division of Allergy & Immunology
Department of Pediatrics
University of South Florida
Morsani College of Medicine
at Johns Hopkins All Children's Hospital
St Petersburg, FL 33701
Sridhar V. Basavaraju, M.D., FACEP (CDR-USPHS)
Expertise: Epidemiology/Infectious Diseases
Blood, Organ, Tissue Safety
Term: 06/28/2021-09/30/2025
Director, Office of Blood, Organ, & Other Tissue Safety
Division of Healthcare Quality Promotion
National Center for Emerging & Zoonotic Infectious Diseases
Centers for Disease Control & Prevention
Atlanta, GA 30329

Evan Bloch, M.D., M.S.
Expertise: Transfusion Medicine/Transfusion transmissible Infections/Babesiosis 
Term: 02/15/2019-9/30/2027
Associate Professor
Associate Director, Transfusion Medicine
Johns Hopkins University School of Medicine
Department of Pathology
Baltimore, MD 21287
Melissa A. Cumming, M.S., CIC
Expertise: Infectious Diseases/Epidemiology, Hemovigilance
Term: 10/01/2021-9/30/2025
Senior Epidemiologist and HAI/AR Program Manager 
Healthcare-Associated Infections and Antibiotic Resistance Program
Bureau of Infectious Diseases and Laboratory Sciences 
Massachusetts Department of Public Health
Jamacia Plain, MA 02130

Susan U. Lattimore, RN, MPH **
Expertise: Consumer Representative
Term: 10/01/2021-09/30/2025
Assistant Professor Pediatrics
Associate Director, The Hemostasis & Thrombosis Center at Oregon Health & Science University 
Portland, OR 97239
Frank Maldarelli, M.D., Ph.D.
Expertise: Virology/HIV/Infectious Diseases 
Term: 10/01/2022-9/30/2026
Senior Investigator 
Head, Clinical Retrovirology Section
National Cancer Institute
National Institutes of Health
Fort Detrick, MD 21702

Traci Mondoro, Ph.D.
Expertise: Hematology/ Transfusion Medicine/Hemostasis/Preclinical and clinical gene and cell therapy
Term: 10/01/2023-09/30/2027
Associate Director, Division of Blood Diseases and Resources
Acting Chief, Blood Epidemiology and Clinical Therapeutics Branch
Program Director, NHLBI Cure Sickle Cell Initiative
Chief, Translational Blood Sciences and Resource Branch
National Heart, Lung and Blood Institute 
National Institutes of Health
Bethesda, MD 20892
Suchitra Pandey, M.D. ***
Expertise: Primary Industry Representative
Term: 10/01/2023-09/30/2027
Chief Medical Officer
Stanford Blood Center
Palo Alto, CA 94304

Elena Perez, M,D., Ph.D., F.A.A.A.A.I.
Expertise: Pediatric Allergy/Immunology
Term: 07/22/2019 - 09/30/2027
Physician
Allergy Associates of the Palm Beaches
Jupiter, FL 33458
Jeremy G. Perkins, MD FACP, COL, US Army (ret)
Expertise: Hematology/Oncology
Term: 10/01/2020-9/30/2028
Deputy Director, Hematopoietic Stem Cell Program
Murtha Cancer Center, Walter Reed National Military Medical Center
Hematology-Medical Oncology Service, Department of Medicine
Associate Professor of Medicine, USUHS
Bethesda, MD 20889

Richard Scanlan, M.D.
Expertise: Transfusion Medicine, Clinical Pathology 
Term: 10/01/2022-9/30/2026
Professor, Vice Chair of Laboratory Medicine 
Transfusion Service 
Medical Director
Oregon Health & Science University 
Portland, OR 97239
Kenneth Sherman, M.D., Ph.D.
Expertise: Virology/Hepatitis
Term: 10/01/2022-9/30/2026
Distinguished Research Professor & Emeritus Professor
University of Cincinnati College of Medicine
Cincinnati, OH 45267 and 
Physician in Medicine
Massachusetts General Hospital
Boston, MA 02114

Abdus Wahed, Ph.D.
Expertise: Biostatistics 
Term: 10/01/2021-09/30/2025 
Professor and Associate Chair
Department of Biostatistics & Computational Biology
University of Rochester
Rochester, NY 14642
Mark A. Becker, MD +
Expertise: Alternate Industry Representative
Term: 10/01/2020-9/30/2027
Sr. Director, Global Plasma Procurement Medical Affairs
Global Plasma Procurement Business Unit
Grifols Plasma
Los Angeles, CA, 90032

 
* Consumer Representative
** Industry Representative
+Alternate Industry Representative
**** Chairperson

Designated Federal Official
Christina Vert, M.S.
Division of Scientific Advisors and Consultants
Center for Biological Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Email: CBERBPAC@fda.hhs.gov
Committee Management Specialist
Tonica Burke, B.S.

Division of Scientific Advisors & Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Email: CBERBPAC@fda.hhs.gov

Director
Prabhakara Atreya, Ph.D.

Division of Scientific Advisors & Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Email: CBERBPAC@fda.hhs.gov
Committee Management Officer
LaShawn Marks
Division of Scientific Advisors & Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Email: CBERBPAC@fda.hhs.gov
Back to Top